___

• 1. Antonescu C., Ladanyi M. Myxoid liposarcoma. In: Fletcher C. D. M., Unni K. K., Mertens F., editors. World Health Organization Classification of Tumors, Pathology and Genetics of Tumors of Soft Tissue and Bone. Lyon, France: IARC Press; 2002. pp. 40–43.2. de Vreeze R. S. A., de Jong D., Haas R. L., Stewart F., van Coevorden F. Effectiveness of radiotherapy in myxoid sarcomas is associated with a dense vascular pattern. International Journal of Radiation Oncology, Biology, Physics. 2008;72(5):1480–1487. doi: 10.1016/j.ijrobp.2008.03.008. 3. Jones R. L., Fisher C., Al-Muderis O., Judson I. R. Differential sensitivity of liposarcoma subtypes to chemotherapy. European Journal of Cancer. 2005;41(18):2853–2860. doi: 10.1016/j.ejca.2005.07.023. 4. Crago AM, Dickson MA. Liposarcoma: multimodality management and future targeted therapies. Surg Oncol Clin N Am. 2016;25(4):761–73. https://doi.org/10. 1016/j.soc.2016.05.007.5. Rosenberg SA, Tepper J, Glatstein E, Costa J, Baker A, Brennan M, et al. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg. 1982;196(3):305–15.6. Trovik CS, Bauer HC, Alvegard TA, Anderson H, Blomqvist C, Berlin O, et al. Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register. Eur J Cancer. 2000;36(6):710–6.7. Gronchi A, Casali PG, Mariani L, Miceli R, Fiore M, Lo Vullo S, et al. Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: a series of patients treated at a single institution. J Clin Oncol. 2005;23(1):96–104. https://doi.org/10.1200/JCO. 2005.04.160.8. Chung PW, Deheshi BM, Ferguson PC, Wunder JS, Griffin AM, Catton CN, et al. Radiosensitivity translates into excellent local control in extremity myxoid liposarcoma: a comparison with other soft tissue sarcomas. Cancer. 2009;115(14):3254–61. https://doi. org/10.1002/cncr.24375.9. Cheng EY, Dusenbery KE, Winters MR, Thompson RC. Soft tissue sarcomas: preoperative versus postoperative radiotherapy. J Surg Oncol. 1996;61(2):90–9. https:// doi.org/10.1002/(SICI)1096-9098(199602) 61:2G90::AID-JSO293.0.CO;2-M.10. Frustaci S, Gherlinzoni F, De Paoli A, Bonetti M, Azzarelli A, Comandone A, et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized Curr. Treat. Options in Oncol. (2018) 19:64 Page 11 of 13 64 cooperative trial. J Clin Oncol. 2001;19(5):1238–47. https://doi.org/10.1200/JCO.2001.19.5.1238.11. Gronchi A, Ferrari S, Quagliuolo V, Broto JM, Pousa AL, Grignani G, et al. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol. 2017;18(6):812–22. https://doi.org/10.1016/S1470- 2045(17)30334-0.